Crestor

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2001-2017
024620012017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Resveratrol is a polyphenol with pleiotropic effects against oxidative damage that has been widely implicated in the lowering of… (More)
Is this relevant?
2012
2012
OBJECTIVE To evaluate the effects of domestic rosuvastatin tablets on coronary plaque in the patients with mild-to-moderate… (More)
Is this relevant?
Review
2004
Review
2004
Rosuvastatin (Crestor) has been recently launched in Belgium by AstraZeneca. This new statin is indicated for the treatment of… (More)
Is this relevant?
2004
2004
 
Is this relevant?
Review
2003
Review
2003
Rosuvastatin (Crestor; licensed to AstraZeneca, Macclesfield, UK from Shionogi, Osaka, Japan) is a new statin with pharmacologic… (More)
Is this relevant?
2003
2003
 
Is this relevant?
Review
2003
Review
2003
Rosuvastatin (Crestor, AstraZeneca) is a synthetic statin that represents an advance on the pharmacologic and clinical properties… (More)
Is this relevant?
2002
2002
An assay employing automated solid-phase extraction (SPE) followed by high-performance liquid chromatography with positive ion… (More)
Is this relevant?
2001
2001
BACKGROUND Rosuvastatin (Crestor), a new, highly efficacious statin, has demonstrated dose-dependent low-density lipoprotein… (More)
Is this relevant?
Review
2001
Review
2001
  • M. Hanefeld
  • International journal of clinical practice
  • 2001
Coronary heart disease (CHD) is the leading cause of death worldwide, and effective treatment of hyperlipidaemia can prevent… (More)
Is this relevant?